Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study identifies genetic risk factor for equine eye cancer
Squamous cell carcinoma (SCC) is the most common cancer of equine eyes.

Discovery will help to inform breeding decisions

Scientists at UD Davis School of Veterinary Medicine have identified the genetic risk factor for equine eye cancer.

Squamous cell carcinoma (SCC) is the most common cancer of equine eyes and the second most common cancer in horses.

Writing in the International Journal of Cancer, researchers announced the discovery of a genetic mutation in horses that is thought to impact the ability of DNA-binding protein 2 (DDB2) to repair UV-light damage.

“The mutation is predicted to alter the shape of the protein so it can't recognise UV-damaged DNA,” said equine geneticist Dr Rebecca Bellone. “We believe this is a risk factor because cells can’t repair the damage and accumulate mutations in the DNA that lead to cancer.”

Ocular SCC can cause blindness and even the loss of the eye. In advanced cases, it can spread to the orbit, eat away at the bone - and eventually the brain - leading to loss of life. The results of this study will be able to inform owners in two ways, as research partner Dr Mary Lassaline explains:

“One, it’s important for the individual horse with a known risk and we can be more vigilant about exams as well as protecting their eyes from UV exposure.  If detected early, we can remove the tumour and save the eye. Secondly, that knowledge is important for making informed breeding decisions.”

Based on the research, scientists at UC Davis Genetics Laboratory were able to develop a genetic test. The test shows if a horse carries the mutation or has two copies of the risk variant, putting it at high risk of cancer.

It is also hoped the research will have implications for human health, as the gene found to be associated with equine SCC is also linked in humans to a skin cancer known as Xeroderma Pigmentosum group E. 

Image (C) UC Davis School of Veterinary Medicine

Become a member or log in to add this story to your CPD history

Reporting service for dead wild birds updated

News Story 1
 The Animal and Plant Health Agency (APHA) has updated its online reporting service for dead wild birds.

The new version allows those reporting a dead bird to drop a pin on a map when reporting the location. It also includes a wider range of wild bird species groups to select from when describing the bird.

The online service, which helps APHA to monitor the spread of diseases such as avian influenza, can be accessed here

Click here for more...
News Shorts
NI chief vet urges bluetongue vigilance

Northern Ireland's chief veterinary officer (CVO) has urged farmers to be vigilant for signs of bluetongue, after the Animal and Plant Health Agency warned there was a very high probability of further cases in Great Britain.

There have been 126 confirmed cases of bluetongue virus serotype 3 in England since November 2023, with no cases reported in Northern Ireland. The movement of live ruminants from Great Britain to Northern Ireland is currently suspended.

According to the Department of Agriculture, Environment and Rural Affairs (DAERA), the virus is most likely to enter Northern Ireland through infected animals or germplasm (semen or ova) being imported.

Brian Dooher, Northern Ireland's CVO, said: "Surveillance for this disease within Northern Ireland has been increased to assist with detection at the earliest opportunity which will facilitate more effective control measures."

Farmers should report any suspicions of the disease to their private veterinary practitioner, the DAERA Helpline on 0300 200 7840 or their local DAERA Direct Veterinary Office.